跳至主要内容
临床试验/NCT00997438
NCT00997438已完成1 期

Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis

Portland VA Medical Center4 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
69
试验地点
4
主要终点
Lipoic Acid Levels

研究概览

简要总结

The purpose of this study is to learn about how the antioxidant, lipoic acid, works in the body and how it may help in the management of relapsing remitting and secondary progressive multiple sclerosis. This study will compare how subject's and healthy volunteers bodies absorb and break down the supplement. This information may help in developing new therapies.

详细描述

Subjects (healthy control, relapsing remitting MS and secondary progressive MS) will be recruited through patients of investigators at Portland VA Medical Center (PVAMC), Oregon Health & Science University (OHSU), and the community using flyers and word of mouth.

The following will occur during screening:

  • Medical History Questionnaire to include questions about drug and alcohol use
  • Self Administered Expanded Disability Status Scale (EDSS) Questionnaire (MS participants only)
  • Vital Signs (heart rate, respiratory rate, blood pressure) will be measured and recorded
  • Physical Exam (MS participants only unless necessary, based on the Medical History Questionnaire or vital signs, to ensure participant safety)
  • Neurological Exam (MS participants only unless necessary, based on the Medical History Questionnaire or vital signs, to ensure participant safety)
  • Weight
  • Urine pregnancy test, if applicable
  • Anemia testing by finger stick (approximately 1 drop)

The rest of the study involves

  • Blood draws before lipoic acid is given, 1 hour, 2 hours, 3 hours, 4 hours, 24 and 48 hours after LA is given (3 ½ tablespoons)
  • Subjects will receive breakfast before they take LA
  • Subjects will take 4 - 300 mg capsules of lipoic acid (LA) for a total of 1200mg with about 1 cup of water

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Lipoic Acid Levels

时间窗: 48 hour

Plasma concentration of LA

cAMP Levels

时间窗: 4 hours

次要结局

  • RANTES Levels(48 hour)

研究者

申办方类型
Fed
责任方
Principal Investigator
主要研究者

Daniel Carr

Research Career Scientist

Portland VA Medical Center

研究点 (4)

Loading locations...

相似试验